Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 604 participants.
Also called NCT07689279
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 604 participants
- Registry
-
NCT07689279
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07689279. Randomized; no masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2033-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement
- Acronym
- SELECT TAVR
- Condition
- Aortic Stenosis, Severe
- Intervention (Device)
- Transcatheter Heart Valve
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Record details
- Record id
cardio:ct-nct07689279- Content hash
58eb74591128ad57ef33bf9fba759207210769ac26af8ee0672a8c32a8c9ddb7